Digital Lifestyle Serve - Money Making Blog
Biogen is abandoning its lackluster Alzheimer’s disease drug, Aduhelm. The Massachusetts-based company announced Wednesday that it is pulling the medication from the market following poor sales and controversy over its…
Millions of Americans and their doctors are in the dark when it comes to early cognitive decline, according to new research from the University of Southern California. A study out…
On Thursday, the Food and Drug Administration made a decision that’s likely to have a major impact on the landscape of Alzheimer’s disease research. The agency issued a full-throated traditional…